HLA class I/NK cell receptor interaction in early human decidua basalis: Possible functional consequences

Chemical Immunology and Allergy

Volumn 89, Issue , 2006, Pages 72-83

  Rabot, Magali ^a   Tabiasco, Julie ^a   Polgar, Beata ^a   Aguerre Girr, Maryse ^a   Berrebi, Alain ^a,b   Bensussan, Armand ^c   Strbo, Natasa ^d   Rukavina, Daniel ^d   Le Bouteiller, Philippe ^a  

^a CHU PURPAN   (France)

^b Paul Sabatier University   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; NATURAL KILLER CELL RECEPTOR; HLA ANTIGEN; IMMUNOGLOBULIN RECEPTOR;

CELL FUNCTION; CELL KILLING; CELL SUBPOPULATION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTROPHOBLAST; DECIDUA; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; TROPHOBLAST; UTERINE ARTERY; BIOLOGICAL MODEL; CLASSIFICATION; FEMALE; IMMUNOLOGY; METABOLISM;

DECIDUA; FEMALE; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; PREGNANCY; RECEPTORS, IMMUNOLOGIC; TROPHOBLASTS;

EID: 27244449802     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (62)

1. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L: What is a natural killer cell? Nat Immunol 2002;3:6-8.
2. Moretta L, Moretta A: Unravelling natural killer cell function: Triggering and inhibitory human NK receptors. EMBO J 2004;23:255-259.
3. Bulmer JN, Lash GE: Human uterine natural killer cells: A reappraisal. Mol Immunol 2005;42:511-521.
4. Chiesa S, Tomasello E, Vivier E, Vély F: Coordination of activating and inhibitory signals in natural killer cells. Mol Immunol 2005;42:477-484.
5. Ferlazzo G, Thomas D, Lin S, Goodman K, Morandi B, Muller WA, Moretta A, Münz C: The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell-Ig-like receptors and become cytolytic. J Immunol 2004;172:1455-1462.
6. Moffett-King A: Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-663.
7. Fisher SJ, Damsky CH: Human cytotrophoblast invasion. Semin Cell Biol 1993;4:183-188.
8. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003;198:1201-1212.
9. Maiza H, Leca G, Mansur IG, Schiavon V, Boumsell L, Bensussan A: A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med 1993;178:1121-1126.
10. Lanier L: Natural killer cell receptor signaling. Curr Opin Immunol 2003;15:308-314.
11. Anumantha A, Bensussan A, Boumsell L, Christ A, Blumberg RS, Voss SD, Patel AT, Robertson MJ, Nadler LM, Freeman GJ: Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 1998;161:2780-2790.
12. Agrawal S, Marquet J, Freeman GJ, Tawab A, Le Bouteiller P, Roth P, Bolton W, Ogg G, Boumsell L, Bensussan A: Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 1999;162:1223-1226.
13. Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, Rabot M, Hilgert I, Mami-Chouaib F, Tabiasco J, Boumsell L, Bensussan A: Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 2002;99:16963-16968.
14. Barakonyi A, Rabot M, Marie-Cardine A, Aguerre-Girr M, Polgar B, Schiavon V, Bensussan A, Le Bouteiller P: Cutting edge: Engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J Immunol 2004;173:5349-5354.
15. King A, Burrows T, Verma S, Hiby S, Loke YW: Human uterine lymphocytes. Hum Reprod Update 1998;4:480-485.
16. Le Bouteiller P, Sargent I: HLA class I molecules in the placenta: Which ones, where and what for? A workshop report. Placenta 2000;21(suppl A):S93-S96.
17. King A, Burrows T, Hiby S, Joseph S, Bowen JM, Verma S, Burrows TD, Loke YW: Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000;21:376-387.
18. King A, Hiby S, Gardner L, Joseph S, Bowen JM, Verma S, Burrows TD, Loke YW: Recognition of trophoblast HLA class I molecules by decidual NK cell receptor. Placenta 2000;21(suppl A):S81-S85.
19. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE: Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003;171:1376-1384.
20. Bainbridge D, Ellis S, Le Bouteiller P, Sargent I: HLA-G remains a mystery. Trends Immunol 2001;22:548-552.
21. Morales PJ, Pace JL, Platt JS, Phillips TA, Morgan K, Fazleabas AT, Hunt JS: Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003;171:6215-6224.
22. Le Bouteiller P, Blaschitz A: The functionality of HLA-G is emerging. Immunol Rev 1999;167:233-244.
23. Kammerer U, von Wolff M, Markert UR: Immunology of human endometrium. Immunobiology 2004;209:569-574.
24. Dosiou C, Giudice L: Natural killer cells in pregnancy and recurrent pregnancy loss: Endocrine and immunological perspectives. Endocr Rev 2005;26:44-62.
25. Drake P, Gunn M, Charo I, Tsou CL, Zhou Y, Huang L, Fisher SJ: Human placental cytotrophoblasts attract monocytes and CD56bright natural killer cells via the actions of monocyte inflammatory protein 1α. J Exp Med 2001;193:1199-1212.
26. Vivier E, Daëron M: Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997;18:286-291.
27. Mandelboim O, Reyburn HT, Sheu EG, Vales-Gomez M, Reyburn HT, Rybalov B, Strominger JL: The binding site of NK receptors on HLA-C molecules. Immunity 1997;6:341-350.
28. Borrego F, Kabat J, Kim DK, Lieto L, Maasho K, Pena J, Solana R, Coligan JE: Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2001;38:637-660.
29. Rajagopalan S, Fu J, Long EO: Cutting edge: Induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001;167:1877-1881.
30. Gomez-Lozano N, De Pablo R, Puente S, Vilches C: Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur J Immunol 2003;33:639-644.
31. Gonen-Gross T, Achdout H, Gazit R, Hanna J, Mizrahi S, Markel G, Goldman-Wohl D, Yagel S, Horejsi V, Levy O, Baniyash M, Mandelboim O: Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol 2003;171:1343-1351.
32. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, Van Der Merwe PA, Kumagai I, Maenaka K: Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003;100:8856-8861.
33. Saverino D, Merlo A, Bruno S, Pistoia V, Grossi CE, Ciccone E: Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol 2002;168:207-215.
34. Pröll J, Bensussan A, Goffin E Foidart JM, Berrebi A, Le Bouteiller P: Tubal versus uterine placentation: Similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 2000;56:479-491.
35. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazeti S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
36. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL: Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999;18:4250-4260.
37. King A, Allan D, Bowen M, Powis S, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM: HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000;30:1623-1631.
38. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004;200:957-965.
39. Varla-Leftherioti M, Spyropoulou-Vlachou M, Keramitsoglou T, Papadimitropoulos M, Tsekoura C, Graphou O, Papadopoulou C, Gerondi M, Stavropoulos-Giokas C: Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion. Hum Immunol 2005;66:65-71.
40. King A, Loke YW, Chaouat G: NK cells and reproduction. Immunol Today 1997;18:64-66.
41. Rukavina D, Podack E: Abundant perforin expression at the maternal-fetal interface: Guarding the semiallogeneic transplant? Immunol Today 2000;21:160-163.
42. Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, Moretta A: Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol 2000;61:1055-1058.
43. Van den Elsen PJ, van der Stoep N, Vietor HE, Wilson L, van Zutphen M, Gobin SJ: Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA. Hum Immunol 2000;61:850-862.
44. King A, Loke Y: Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2-stimulated decidual NK cells. Cell Immunol 1990;129:435-448.
45. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G: X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 2004;10:33-41.
46. Szekeres-Bartho J: Immunological relationship between the mother and the fetus. Int Rev Immunol 2002;21:471-495.
47. Laskarin G, Tokmadzic V, Strbo N, Bogovic T, Szekeres-Bartho J, Randic L, Podack ER, Rukavina D: Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol 2002;48:201-209.
48. Saito S, Nishikawa K, Morii T, Enomoto M, Narita N, Motoyoshi K, Ichijo M: Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol 1993;5:559-563.
49. Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW: Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 1994;153:4427-4435.
50. Van Der Meer A, Lukassen HG, Van Lierop MJ, Wijnands F, Mosselman S, Braat DD, Joosten I: Membrane-bound HLA-G activates proliferation and interferon-γ production by uterine natural killer cells. Mol Hum Reprod 2004;10:189-195.
51. Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K, Licence D, Bowen JM, Gardner L, King A, Loke YW, Smith SK: Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001;86:1823-1834.
52. Stallmach T, Ehrenstein T, Isenmann S, Muller C, Hengartner H, Kagi D: The role of perforin-expression by granular metrial gland cells in pregnancy. Eur J Immunol 1995;25:3342-3348.
53. Croy BA, He H, Esadeg S, Wei Q, McCartney D, Zhang J, Borzychowski A, Ashkar AA, Black GP, Evans SS, Chantakru S, van den Heuvel M, Paffaro VA Jr, Yamada AT: Uterine natural killer cells: Insights into their cellular and molecular biology from mouse modelling. Reproduction 2003; 126:149-160.
54. Zhang JH, He H, Borzychowski AM, Takeda K, Akira S, Croy BA: Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol Reprod 2003;69:404-411.
55. Trundley A, Moffett A: Human uterine leukocytes and pregnancy. Tissue Antigens 2004;63:1-12.
56. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C: HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003;59:219-234.
57. Cooper M, Fehniger T, Caligiuri M: The biology of human natural killer-cell subsets. Trends Immunol 2001;22:633-640.
58. Barel M, Pizzato N, van Leeuwen D, Le Bouteiller P, Wiertz EJHJ, Lenfant F: Amino acid composition of α1/α2 domains and cytoplasmic tail of MHC class I molecules determines their susceptibility to human cytomegalovirus US11-mediated down-regulation. Eur J Immunol 2003;33:1707-1716.
59. Barel MT, Ressing M, Pizzato N, van Leeuwen D, Le Bouteiller P, Lenfant F, Wiertz EJ: Human cytomegalovirus-encoded Unique Short 2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J Immunol 2003;171:6757-6765.
60. Huddleston H, Schust D: Immune interactions at the maternal-fetal interface: A focus on antigen presentation. Am J Reprod Immunol 2004;51:283-289.
61. Derrien M, Pizzato N, Dolcini G, Menu E, Chaouat G, Lenfant F, Barré-Sinoussi F, Le Bouteiller P: Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical MHC class I molecule HLA-G. J Gen Virol 2004;85:1945-1954.
62. Lewis BJ, Croker S, Newton DJ, Lennon GP, Johnson PM, Christmas SE: Natural killer cell receptor expression by human first trimester decidual granular leukocytes and T-lymphocytes. Am J Reprod Immunol 2002;48:103-109.